The first part is in my profile.
It makes me feel vulnerable to share, but we have benefited enormously from reading others' stories, so I'm sharing.
UPDATE:
8/18/21 PSA =0.45
9/6/21 last dose Orgovyx
9/7/21 First Eligard 3 month shot
9/17/21 PSA =0.78
10/18/21 PSA =1.28
Nov not tested
12/18/21 PSA =5.9
2022
Nubeqa started 1/6/22
01/20/22 PSA =2.14
03/03/22 PSA =0.64
4/20/22 PSA =0.27
6/01/22 PSA =0.18
7/19/22 PSA =0.10
8/26/22 PSA =0.05
11/04/22 PSA =0.03
12/21/22 PSA =0.04
02/08/23 PSA = 0.06
03/20/2023 PSA=0.26
Started at VUMC w Schaffer
4/25/2023 PSA: 1.31
5/4/23 ALP 104
5/10/2023 PSMA scan showed mixed response - decreased uptake of previously seen RP and iliac LN, a few new sites of nodal disease
6/19/23 - Aug 2023 Provenge started
6/19/23 PSA 11.73 ALP 101
6/19/23 Lupron 3 month dose
7/17/23 last dose Provenge
Aug 2023 PSA rise 25.6
8/8/2023 CT CAP and NM bone scan show slight disease progression with increased LAD and new focus of radiotracer uptake in 5th rib
Aug 2023 consult w DrDenmeade re BAT
Aug 2023 discontinued darolutamide in preparation for BAT
9/7/23 PSA 74, ALP 132
9/13/23 CT CAP and NM bone scan show stable disease / uptake from prior. Multiple osseous sites
10/4/23 PSA 70.15, ALP 138
Started BAT - October 2023 - December 2023 received testosterone cypionate 400 mg monthly while continuing Lupron
11/1/23 PSA 71.27, ALP 159
11/30/23 PSA 57.38, ALP 185
12/28/23 47.73, ALP 221
1/23/24 PSA 128 T 538, ALP 284
1/18/24 CT CAP shows increased RP LN and new multifocal osseous lesions. CT confirmed small segmental PE in RLL .NM bone scan shows increased uptake new compared to prior (9-2023) calvarium, shoulders, ribs, sternum, C, T and L spine, pelvis and proximal femurs. Rib lesions increased in size and intensity from prior. Doppler Venous lower extremities no DVT
1/29/24 Darolutamide resumed
2/5/24 PSA 88, T 171
2/19/24 PSA 98, T 128, ALP 381
3/4/24 PSA 209, T 61, ALP 412
Going for scan to set up SBRT for painful mets today which will be done after trip to Mayo to see Sartor (3/12/24)
Dramatic changes in bone involvement from September to January. Went from mostly nodal disease to widespread mets throughout skeleton.
Frustrated more wasn't suggested earlier. We only saw NP during BAT treatments at VU, T was not measured. PSA was going down (from 71 to 47), but Alkaline Phosphatase was going up and we brought it to the attention of the NP but were essentially dismissed, since PSA was falling.
It's frustrating when you go in to your doctor informed and asking good questions but basically being told to wait till you have more disease.
He has not had chemo.
We've been researching AC225 overseas, but very expensive.
Hoping for good direction from Dr. Sartor next week.
If you read it all, thank you.